Resilience and Lilly Invest $750M to Scale Cincinnati Medicine Output

Resilience and Lilly invest $750M to scale Cincinnati medicine output

The expansion will create 400 jobs dedicated to GLP-1 injectables production across Resilience’s contract manufacturing facilities.

Drugmakers plan $750M expansion in suburban Cincinnati, will create 400 jobs

Cincinnati Lands $750M Lilly Expansion With 400 New Jobs

Resilience and Eli Lilly will invest $750 million in Cincinnati-area manufacturing, adding at least 400 jobs and KwikPen production by early 2027.

Resilience, Lilly to increase US medicines production with $750m investment

The investment will support the expansion of Resilience’s advanced manufacturing operations in the Cincinnati region and create at least 400 new jobs. With this initiative, the total number The post Resilience and Lilly to increase US medicines production with $750m investment appeared first on Pharmaceutical Business review.